TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive Review Of Cancer Center supports Grants Needs Refocus On Science, Advisors Say October 18, 1996
TCL Archive New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics December 10, 1999
